Skip to content

Aging (Aging-US) Authors

Aging-US.net Authors

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • Pinterest
  • SoundCloud
  • Reddit
  • Home
  • News

Aging (Aging-US) Authors

Fibroblast Growth Factor 21 and Survival in the Elderly: Polsenior2 Study Results
Aging News

Fibroblast Growth Factor 21 and Survival in the Elderly: Polsenior2 Study Results

October 17, 2024October 17, 2024

PRESS RELEASE – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science), Volume 16, Issue 19 on September 18, 2024, entitled, “Fibroblast growth factor 21 inversely correlates with survival in elderly population – the results of the Polsenior2 study.”

Read More
Figure 3. High-glucose induced hyperlipidemia through FoxO6-mediated ApoC3 expression.
Aging News

FoxO6-mediated ApoC3 Upregulation Promotes Hepatic Steatosis and Hyperlipidemia in HFD Aged Rats

March 20, 2024

PRESS RELEASE: On March 3, 2024, a new research paper was published in Aging’s Volume 16, Issue 5, entitled, “FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.”

Read More
Figure 4. Prediction model performance.
Aging News

Living Donor Liver Transplant Access is Optimal for High-risk Waitlisted Cirrhosis Patients

September 26, 2023September 26, 2023

PRESS RELEASE: A new research paper was published in Aging’s Volume 15, Issue 17, entitled, “Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients.”

Read More
  • twitter

Copyright © 2023 Impact Journals, LLC

Impact Journals is a registered trademark of Impact Journals, LLC